TNM Staging | AJCC 2017
The TNM staging system anatomically classifies malignancies based on the extent of the primary tumour, regional lymph node involvement, and distant metastases. Staging helps physicians decide eligibility for clinical trials, define a patient's prognosis, and determine best treatment options.
The American Joint Committee on Cancer (AJCC) publishes the AJCC Cancer Staging Manual every 6-8 years. This tool is based on the 8th edition (2017) which represents the most up to date TNM staging guide.
Anatomic Stage/Prognostic Groups
| Stage I | T1 | N0 | M0 |
| Stage II | T2 | N0 | M0 |
| Stage III | T1 or T2 T3 |
N1 N0 or N1 |
M0 M0 |
| Stage IV | T4 Any T |
Any N Any N |
M0 M1 |
American Joint Committee on Cancer (AJCC).
The TNM staging system anatomically classifies malignancies based on the extent of the primary tumour, regional lymph node involvement, and distant metastases. Staging helps physicians decide eligibility for clinical trials, define a patient's prognosis, and determine best treatment options.
The American Joint Committee on Cancer (AJCC) publishes the AJCC Cancer Staging Manual every 6-8 years. This tool is based on the 8th edition (2017) which represents the most up to date TNM staging guide.
Anatomic Stage/Prognostic Groups
| Stage I | T1 | N0 | M0 |
| Stage II | T2 | N0 | M0 |
| Stage III | T1 or T2 T3 |
N1 N0 or N1 |
M0 M0 |
| Stage IV | T4 Any T |
Any N Any N |
M0 M1 |
American Joint Committee on Cancer (AJCC).
© 2020 QxMD Software Inc., all rights reserved. No part of this service may be reproduced in any way without express written consent of QxMD. This information should not be used for the diagnosis or treatment of any health problem or disease. This information is not intended to replace clinical judgment or guide individual patient care in any manner. Click here for full notice and disclaimer.
